We are catalyzing
innovation to accelerate
a solve for FSHD
Our purpose is to solve FSHD by December 31, 2027 with a focus on all forms of this rare neuromuscular disease. We will do this by removing barriers and accelerating development of novel therapies for FSHD.
Who We Are
Driving Innovation Toward
a Cure for FSHD
SOLVE FSHD is a venture philanthropic organization founded on the generous commitment of $100M USD from the Wilson family. We are part of a larger global FSHD community that has brought us to a place and time where cures for FSHD are possible. As a mission-driven organization, our unique approach is to be a catalyst, making strategic investments through partners in leading academic, biotech and biopharmaceutical organizations.
We will work with our partners and advisors in the life sciences community to develop a pipeline of new therapies and a solve by December 31, 2027. Once we have a solve for FSHD we will continue to support the ongoing needs of this global community.
What is FSHD?
Facioscapulohumeral muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is a type of muscular dystrophy in which there is progressive muscle degeneration and muscle weakness. There is currently no treatment or cure.
Find Support
Resources for Living With FSHD
Explore a network of organizations providing information, guidance, advocacy, direct support, and access to clinical trials for potential new therapies.